...
机译:二甲双胍介导的P38丝裂原激活蛋白激酶依赖性切除修复交叉互补1降低DNA修复能力并使人肺癌细胞敏感到紫杉醇
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
Molecular Oncology Laboratory Department of Biochemical Science and Technology National Chiayi;
ERCC1; Metformin; Non-small cell lung cancer; p38 MAPK; Paclitaxel;
机译:二甲双胍介导的P38丝裂原激活蛋白激酶依赖性切除修复交叉互补1降低DNA修复能力并使人肺癌细胞敏感到紫杉醇
机译:CDK4 / 6抑制剂对PARP1转录的下调通过削弱OGG1依赖性碱基切除修复而使人肺癌细胞对抗癌药物诱导的死亡敏感
机译:脱甲氧基姜黄素诱导的DNA损伤降低了NCI-H460人肺癌细胞中DNA修复相关的蛋白表达水平。
机译:DNA修复基因X射线修复交叉互补组1(XRCC1)中肺癌风险与多态性之间的关联
机译:预测细胞内蛋白质变异对人类细胞碱基切除修复能力的影响。
机译:CDK4 / 6抑制剂对PARP1转录的下调通过削弱OGG1依赖性碱基切除修复而使人肺癌细胞对抗癌药物诱导的死亡敏感
机译:P38 Mapk依赖性切除修复交叉互补1表达的抑制降低了DNA修复能力,使肺癌细胞敏化到依托普苷
机译:DNa碱基切除修复(BER)和癌症基因治疗:使用人类N-mythlpurien DNa糖基化酶(mpG)使乳腺癌细胞对低剂量化疗敏感